Living With Frontotemporal Dementia

Adaptation Clinical Trial

Official title:

Challenges of Living With Frontotemporal Dementia: The Perspective of the Affected Individual

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT01738386
• Other study ID #: 999912153
• Secondary ID: 12-HG-N153
• Status: Terminated
• Start date: June 13, 2012
• Est. completion date: February 24, 2016

Study information

• Verified date: February 24, 2016
• Source: National Institutes of Health Clinical Center (CC)
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Background:

• Frontotemporal dementia (FTD) is the second most common cause of early-onset dementia. Alzheimer s disease is the most common. Alzheimer s disease happens most often in the elderly, but FTD typically appears between 40 and 60 years of age. It also has a strong genetic component: Up to 40% of FTD cases are linked to positive family histories. Earlier diagnoses and genetic tests mean that people with FTD will spend more years in earlier stages of disease, aware that they have it. However, few studies have looked at the personal experiences or coping styles of people with FTD. Researchers want to interview people with FTD and their caregivers to understand their experiences with the disease. This information will help create better treatments and therapies for those affected by FTD.

Objectives:

• To study the experiences of persons with FTD and their primary caregivers.

Eligibility:

• Individuals at least 18 years of age who have been diagnosed with FTD.

• Primary caregivers (spouse or partner at least 18 years of age) of individuals who have been diagnosed with FTD.

Design:

• Before FTD participants are recruited, a pilot study will test the interview questions. This pilot study will be given to people with Alzheimer s disease and their caregivers. It will study how well people with dementia understand the interview questions.

• FTD study participants will be recruited through dementia care centers.

• All participants will have in-person interviews. These interviews will take up to 1 hour.

• Participants with FTD will answer questions about their experience with the disease. They will talk about their mental abilities, challenges, and coping strategies.

• Caregivers will answer questions about their experience in caring for someone with FTD. They will talk about their challenges and coping strategies. They will also talk about the person with FTD, and how aware they believe that the person is of the dementia symptoms.

• All participants will receive a small gift card as compensation for their time.

• No treatment will be provided as part of this study.

Description:

The purpose of the proposed study is to qualitatively explore the experience, conceptualization of disease, and coping strategies of persons with frontotemporal dementia (FTD). FTD is the second most prevalent cause of early-onset dementia after Alzheimer disease, and has a significant genetic origin. Currently, there are no published studies describing the personal experience or coping styles of individuals with FTD. To accomplish the study s objectives, semi-structured interviews will be conducted with 20 to 30 dyads of patients with FTD and their spouse/partner caregivers. The caregivers will be interviewed about the experience of the person with FTD. Both sets of interviews will be audiotaped, transcribed and subjected to thematic content analysis. Themes emerging in both members of each dyad will be compared and contrasted in order to understand the subjective experience of the disease. Insight into the personal illness experiences of individuals with FTD will inform future clinical intervention studies.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 16
• Est. completion date: February 24, 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

• INCLUSION AND EXCLUSION CRITERIA:

Participants with FTD must:

• Be affected with any variant of frontotemporal dementia and have documented cognitive impairment

• Have this diagnosis made by a behavioral neurologist, neuropsychologist, psychiatrist, or a group consensus of any of the above in a specialized dementia center

• For patients recruited through the contact physicians at Johns Hopkins Hospital, University of Pennsylvania, or Columbia University Medical Center, this diagnosis will be verified through personal communication between the interviewer (WM) and the contact physician and through the patients medical records.

• For patients recruited through a foundation, patient support group or Clinicaltrials.gov, the patients listed dementia care specialist will be contacted to verify the diagnosis, or the appropriate documents obtained through a release of medical information form.

• Be assessed to be in the none (1) to mild (2) impairment category on the Dementia Disability Rating. The assessment must be performed by a dementia care specialist with a medical degree.

• Have an onset of disease at or more than three months before the interview date. This date may or may not differ from the actual date of diagnosis.

• Pass the consent comprehension assessment

• Be 18 or older and speak fluent English

Caregivers participants must:

• Be a spouse or partner who provides day-to-day care for the affected individual.

• Spend a minimum of 16 hours per week, on average in a month, in direct contact with the affected individual.

• NOT be a non-spousal relative, friend, healthcare provider, or hired help.

• Pass the consent comprehension assessment

• Be 18 or older and speak fluent English.

Related Conditions & MeSH terms

• Adaptation
• Aphasia, Primary Progressive
• Dementia
• Frontotemporal Dementia
• Pick Disease of the Brain

Locations

Country	Name	City	State
United States	Johns Hopkins University	Baltimore	Maryland
United States	Columbia University	New York	New York
United States	University of Pennsylvania	Philadelphia	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
National Human Genome Research Institute (NHGRI)

Country where clinical trial is conducted

United States, 

References & Publications (3)

Ablitt A, Jones G, Muers J. Awareness of carer distress in people with dementia. Int J Geriatr Psychiatry. 2010 Dec;25(12):1246-52. doi: 10.1002/gps.2461. — View Citation

Baldelli MV, Pirani A, Motta M, Abati E, Mariani E, Manzi V. Effects of reality orientation therapy on elderly patients in the community. Arch Gerontol Geriatr. 1993 Nov-Dec;17(3):211-8. — View Citation

Bates J, Boote J, Beverley C. Psychosocial interventions for people with a milder dementing illness: a systematic review. J Adv Nurs. 2004 Mar;45(6):644-58. Review. — View Citation